Sapanisertib and Ziv-Aflibercept in Treating Patients With Recurrent Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery

Clinical trial NCT02159989 · COMPLETED

Trial details

NCT number: NCT02159989
Sponsor: National Cancer Institute (NCI)
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Malignant Solid Neoplasm Fibrolamellar Carcinoma Metastatic Malignant Solid Neoplasm Ovarian Carcinoma Pancreatic Neuroendocrine Tumor Recurrent Malignant Solid Neoplasm Refractory Malignant Solid Neoplasm Unresectable Solid Neoplasm

Start date: 2014-06-18
Primary completion: 2021-06-29
Enrollment: 83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.